Enrolling Studies

MK-018

You may qualify for this study if the following applies to you:

  • HIV positive
  • Viral Load of greater than or equal to 1,000 copies/mL
  • No previous use of HIV medications

GS-1160

You may qualify for this study if the following applies to you:

  • Currently taking Atripla for 6 consecutive months or more
  • Viral Load of less than 50 copies/mL for greater than or equal to 6 consecutive months
  • Cannot be Hepatitis B (HBsAg) positive
  • Cannot be Hepatitis C antibody positive with detectable HCV RNA (if not detectable, then possibly eligible)

GS-1216

You may qualify for this study if the following applies to you:

  • Currently taking Complera for 6 consecutive months or more
  • Viral Load of less than 50 copies/mL for greater than or equal to 6 consecutive months

A5332

You may qualify for this study if the following applies to you:

  • Must have taken HIV medications for at least 180 days prior to study entry
  • CD4 greater than 100
  • Ages between 40 to 75
  • Fasting LDL cholesterol less than 190 mg/dL
  • Fasting triglycerides less than 500 mg/dL
  • Must not have had cancer within 36 months prior to study entry
  • Must not have serious illness or trauma requiring systemic treatment or hospitalization in the 30 days prior to study entry
  • Diabetes - LDL cannot be greater 70 mg/dL

Florida Cohort Project (Survey)

You may qualify for this study if the following applies to you:

  • HIV positive or negative
  • Documented HIV status (laboratory results for both positive and negative participants)
  • Demonstrate a complete understanding of the English language (reading, writing, and speaking)